Lars H. Lindner
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
-
- Sarcoma Diagnosis and Treatment
Papers in
-
- Sarcoma Diagnosis and Treatment 61
- Oncology 38
- Vascular Tumors and Angiosarcomas 16
- Co-authors
- Rolf D. Issels (47 shared papers)Martin Hossann (24 shared papers)Timo L.M. ten Hagen (5 shared papers)Gerben A. Koning (5 shared papers)Michael Peller (12 shared papers)Gerhard Winter (5 shared papers)Hans Roland Dürr (29 shared papers)Andrea Baur‐Melnyk (10 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)Cancers (13 papers)International Journal of Hyperthermia (11 papers)Journal of Controlled Release (10 papers)Meteoritics and Planetary Science (8 papers)
- Partner nations
- GermanyNetherlandsFrance
In The Last Decade
Lars H. Lindner
192 papers receiving 5.0k citations
Lars H. Lindner's Hit Papers
Peers
Comparison fields: 5 of 125
- Biomaterials 1.6k
- Pulmonary and Respiratory Medicine 1.2k
- Biomedical Engineering 1.8k
- Pharmaceutical Science 211
- Gastroenterology 133
Countries citing papers authored by Lars H. Lindner
This map shows the geographic impact of Lars H. Lindner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars H. Lindner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars H. Lindner more than expected).
Fields of papers citing papers by Lars H. Lindner
This network shows the impact of papers produced by Lars H. Lindner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars H. Lindner. The network helps show where Lars H. Lindner may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars H. Lindner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 205 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study Hit paper breakdown → | 2010 | 490 |
| 2 | 2012 | 379 | |
| 3 | 2014 | 281 | |
| 4 | 2004 | 206 | |
| 5 | 2010 | 205 | |
| 6 | 2010 | 175 | |
| 7 | 2018 | 125 | |
| 8 | 2007 | 112 | |
| 9 | 2012 | 111 | |
| 10 | 2020 | 103 | |
| 11 | 2017 | 94 | |
| 12 | 2010 | 92 | |
| 13 | 2016 | 90 | |
| 14 | 2017 | 88 | |
| 15 | 2014 | 74 | |
| 16 | Factors affecting drug release from liposomes. | 2010 | 73 |
| 17 | 2012 | 69 | |
| 18 | 2002 | 68 | |
| 19 | 2018 | 62 | |
| 20 | 2007 | 60 |
About Lars H. Lindner
Lars H. Lindner is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Biomedical Engineering, Molecular Biology and Biomaterials, having authored 205 papers that have together received 5.1k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (61 papers), Nanoparticle-Based Drug Delivery (22 papers), Ultrasound and Hyperthermia Applications (19 papers), RNA Interference and Gene Delivery (18 papers), Vascular Tumors and Angiosarcomas (16 papers), Virus-based gene therapy research (10 papers), Nuclear Physics and Applications (10 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). The work is most often cited by research in Biomaterials (1.6k citations), Pulmonary and Respiratory Medicine (1.2k citations), Biomedical Engineering (1.8k citations), Pharmaceutical Science (211 citations) and Gastroenterology (133 citations). Lars H. Lindner has collaborated with scholars based in Germany, Netherlands and France. Frequent co-authors include Rolf D. Issels, Martin Hossann, Timo L.M. ten Hagen, Gerben A. Koning, Michael Peller, Gerhard Winter, Hans Roland Dürr, Andrea Baur‐Melnyk, Thomas Knösel and Alexander M.M. Eggermont. Their work appears in journals such as Journal of Clinical Oncology, Cancers, International Journal of Hyperthermia, Journal of Controlled Release and Meteoritics and Planetary Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.